E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/26/2013 in the Prospect News PIPE Daily.

Elite chairman converts $1 million 10% credit line to convertibles

Interest-free unsecured convertible notes will be due in November 2016

By Devika Patel

Knoxville, Tenn., Nov. 26 - Elite Pharmaceuticals Inc. said its chairman of the board, Jerry Treppel, has chosen to convert the principal of his $1 million credit line into an unsecured convertible note.

The credit line accrues interest at 10% and is due on July 31, 2014. The remaining $600,000 of principal under the credit line has now been converted to an interest-free, convertible note, which matures in November 2016.

Based in Northvale, N.J., Elite develops oral controlled-release products.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.